Octagon Capital Advisors LP MLTX Holdings History
Octagon Capital Advisors LP's MoonLake Immunotherapeutics Holding Summary
As of 2025-03-31, Octagon Capital Advisors LP held 296,000.00 shares of MoonLake Immunotherapeutics(MLTX), totaling $11.56 Mil. This investment constitutes 2.24% of their stock portfolio, and Octagon Capital Advisors LP now holds 0.47% of the outstanding MoonLake Immunotherapeutics(MLTX) stock.
The initial trade took place in 2025Q1. And since then Octagon Capital Advisors LP has made 1 purchases of MLTX, at an average price of $43.09, for a total of 296,000.00 shares. Based on historical transaction data and MLTX's current price of $48.07, Octagon Capital Advisors LP's estimated gain on his MLTX holdings is $1.47 Mil, reflecting a 11.55% gain to date.
Octagon Capital Advisors LP MLTX ($48.07) Holding Chart
Octagon Capital Advisors LP MLTX ($48.07) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
